EUVIMEDEUVIMED entdecken
FallberichtSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Clinical manifestations, diagnosis and treatment of hereditary fibrinogen Aα-chain renal amyloidosis: one case report and systematic review

Linying He, Jiahui Zhou, Miner Wang, Jianxiang Chen, Chang Liu, Jiazhen Shi, Yanxia Rui, Henglan Wu

International Urology and Nephrology · 17.10.2024 · 57 (2) · 517-533

DOI: 10.1007/s11255-024-04236-w ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Urology and Nephrology, online erschienen am 17.10.2024. Verfasst von Linying He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Chinese Medical University, Hangzhou, 310000, Zhejiang, China. Hauptthemen laut MEDLINE: Amyloidosis, Fibrinogen, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Kind by the Jiaxing Key Disci- pline of Medcine-Nephrology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: We reported a confirmed case of Fibrinogen Aa-chain (AFib) amyloidosis and conducted systematic review of the genetic and protein mutation types, clinical manifestations, diagnostic methods and treatment for patients with this disease worldwide. METHODS: We reported a case of AFib amyloidosis. Meanwhile, a systematic search was performed using defined terms and updated up to November 2023 in the Wanfang, China National Knowledge Infrastructure, VIP, PubMed, and Web of Science databases to identify reported cases of AFib renal amyloidosis worldwide, according to PRISMA guidelines. RESULTS: A 46-year-old male patient was admitted for more than half a month because of oedematous lower limbs. Renal tissue mass spectrometry suggested an AFib type. Gene detection demonstrated that the patient carried the c.1673del (p.Lys558Argfs*10) locus heterozygous mutation of Fibrinogen Aα-chain gene (FGA). The patient was treated with haemodialysis because of uncontrollable hypertension. This systematic review comprised 46 cases. We found the onset age to be lower in women than in men (P < 0.05). All patients showed incipient symptoms including proteinuria; 10 (21.7%) patients progressed to end-stage renal disease (ESRD) or received renal replacement therapy (including dialysis and kidney transplantation) within 1 year; 18 (39.1%) patients progressed to ESRD or received renal replacement therapy within 1-5 years, and 4 (8.7%) patients did not progress to ESRD or received renal replacement therapy within 5 years. CONCLUSION: AFib amyloidosis progresses rapidly. The diagnosis of this disease is primarily based on renal biopsy, mass spectrometry, and molecular gene detection. Reducing proteinuria is the main method of treating this disease. PROSPERO REGISTRATION NUMBER: CRD42024516146.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisFibrinogenKidney DiseasesHumansMaleMiddle Aged

Stichwörter der Autor:innen

AmyloidFibrinogen Aα-chainKidneyRenal amyloidosis

Substanzen

Fibrinogenfibrinogen Aalpha

Autor:innen und Institutionen

  • Zhejiang Chinese Medical University, Hangzhou, 310000, Zhejiang, China.
  • Department of Nephrology, The First Hospital of Jiaxing, First Affiliated Hospital of Jiaxing University, Jiaxing, 314000, Zhejiang, China.
  • Department of Nephrology, The First Hospital of Jiaxing, First Affiliated Hospital of Jiaxing University, Jiaxing, 314000, Zhejiang, China. 676682577@qq.com.
  • Department of Nephrology, The First Hospital of Jiaxing, First Affiliated Hospital of Jiaxing University, Jiaxing, 314000, Zhejiang, China. whl525487@sina.com.

Förderung

  • Kind by the Jiaxing Key Disci- pline of Medcine-Nephrology

Zitieren

APA

He, L., Zhou, J., Wang, M., Chen, J., Liu, C., Shi, J., Rui, Y., & Wu, H. (2024). Clinical manifestations, diagnosis and treatment of hereditary fibrinogen Aα-chain renal amyloidosis: one case report and systematic review. International Urology and Nephrology, 57(2), 517-533. https://doi.org/10.1007/s11255-024-04236-w

Vancouver

He L, Zhou J, Wang M, Chen J, Liu C, Shi J, et al. Clinical manifestations, diagnosis and treatment of hereditary fibrinogen Aα-chain renal amyloidosis: one case report and systematic review. International Urology and Nephrology. 2024;57(2):517-533. doi:10.1007/s11255-024-04236-w

BibTeX
@article{He2024,
  author = {He, Linying and Zhou, Jiahui and Wang, Miner and Chen, Jianxiang and Liu, Chang and Shi, Jiazhen and Rui, Yanxia and Wu, Henglan},
  title = {Clinical manifestations, diagnosis and treatment of hereditary fibrinogen Aα-chain renal amyloidosis: one case report and systematic review},
  journal = {International Urology and Nephrology},
  year = {2024},
  volume = {57},
  number = {2},
  pages = {517--533},
  doi = {10.1007/s11255-024-04236-w}
}
Kostenlos starten →